Introducing Regulatory Writing at Aspire – Meet Helena Pigeon

We are delighted to welcome Helena Pigeon as Regulatory Writing Director, marking the launch of our Regulatory Writing capability at Aspire.
At Aspire, everything starts with evidence, and how clearly we communicate it. Our Regulatory Writing service builds on this, supporting multi-functional client teams to communicate complex data clearly through high-quality clinical regulatory documentation. From investigational new drug applications through to submissions to regulatory authorities, our focus is developing clear, lean documents that are accurate, compliant, and fit for purpose.
Helena brings more than 20 years’ experience in regulatory writing, with a PhD in Cell Biology. Her expertise spans a broad range of clinical regulatory documents and therapy areas, with experience in both delivery and strategic oversight. She also brings a strong track record in mentoring and developing teams – something that will be central as we grow this capability at Aspire.
Please join us in welcoming Helena to the team!